This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takano, H. Articles by Kuwano, M. Search for Related Content PubMed PubMed Citation Articles by Takano, H. Articles by Kuwano, M.

Increased Phosphorylation of DNA Topoisomerase II in Etoposide-resistant Mutants of Human Cancer KB Cells¹

Departments of Biochemistry [H. T., K. K., M. O., M. K.] and Surgery II [Y. U.], Oita Medical School, Hasama-machi, Oita 879-56, Japan

We have isolated two etoposide (VP16)-resistant cell lines, KB/VP-1 and KB/VP-2, from human cancer KB cells after stepwise exposure to increasing doses of VP16. KB/VP-1 and KB/VP-2 showed 30- and 50-fold higher resistance to VP16 and also 20- and 30-fold higher resistance to teniposide than the parent cell line. Furthermore, both resistant cell lines showed more than 2-fold cross-resistance to Adriamycin and daunomycin than KB cells. The levels of accumulation and outward transport of radioactive VP16 were similar in KB/VP-1, KB/VP-2, and KB. The activity of nuclear extracts of DNA topoisomerase II for both KB/VP-1 and KB/VP-2 assayed by decatenation of kinetoplast DNA was consistently similar to that of KB. However, in both immunoblot assay with specific anti-topoisomerase II antibody and Northern blot analysis with specific human DNA topoisomerase II complementary DNA, cellular levels of topoisomerase II in both resistant cell lines were less than one-tenth the level in KB. The cellular levels of DNA topoisomerase I, however, were similar between the mutants and their parent. A quantitative precipitation assay of covalent DNA-topoisomerase II complexes showed greatly reduced VP16-induced cleavages of 3'-³²P-DNA by nuclear extracts of KB/VP-1 or KB/VP-2 cells in comparison with KB cells. The relative specific phosphorylation of DNA topoisomerase II was about 14- to 18-fold higher in the mutants than in the parental cells. Phosphoamino acid analysis of DNA topoisomerase II showed that serine was the phosphorylated amino acid in all three cell lines, KB, KB/VP-1, and KB/VP-2. These data suggest that reduced expression of DNA-topoisomerase II might account for the acquired VP16 resistance and reduced VP16-induced cleavages of DNA-topoisomerase II complexes in both VP16-resistant variants.

¹ This study was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, Japan; a Research Grant of the Princess Takamatsu Cancer Research Fund; and also by the U.S.-Japan cooperative cancer research program.

² To whom requests for reprints should be addressed.

Received 2/ 1/91. Accepted 5/24/91.

This article has been cited by other articles:

				K. Chikamori, D. R. Grabowski, M. Kinter, B. B. Willard, S. Yadav, R. H. Aebersold, R. M. Bukowski, I. D. Hickson, A. H. Andersen, R. Ganapathi, et al. Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIalpha Regulates Enzymatic Activity and Drug Sensitivity J. Biol. Chem., April 4, 2003; 278(15): 12696 - 12702. [Abstract] [Full Text] [PDF]

				I. Plo, H. Hernandez, G. Kohlhagen, D. Lautier, Y. Pommier, and G. Laurent Overexpression of the Atypical Protein Kinase C zeta Reduces Topoisomerase II Catalytic Activity, Cleavable Complexes Formation, and Drug-induced Cytotoxicity in Monocytic U937 Leukemia Cells J. Biol. Chem., August 23, 2002; 277(35): 31407 - 31415. [Abstract] [Full Text] [PDF]

				H. Sakamoto, T. Mashima, A. Kizaki, S. Dan, Y. Hashimoto, M. Naito, and T. Tsuruo Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis Blood, May 15, 2000; 95(10): 3214 - 3218. [Abstract] [Full Text] [PDF]

				P. Muñoz, M. Z. Zdzienicka, J.-M. Blanchard, and J. Piette Hypersensitivity of Ku-Deficient Cells toward the DNA Topoisomerase II Inhibitor ICRF-193 Suggests a Novel Role for Ku Antigen during the G2 and M Phases of the Cell Cycle Mol. Cell. Biol., October 1, 1998; 18(10): 5797 - 5808. [Abstract] [Full Text]

				M. Furukawa, T. Uchiumi, M. Nomoto, H. Takano, R. I. Morimoto, S. Naito, M. Kuwano, and K. Kohno The Role of an Inverted CCAAT Element in Transcriptional Activation of the Human DNA Topoisomerase IIalpha Gene by Heat Shock J. Biol. Chem., April 24, 1998; 273(17): 10550 - 10555. [Abstract] [Full Text] [PDF]

				T. Sumizawa, Z.-S. Chen, Y. Chuman, K. Seto, T. Furukawa, M. Haraguchi, A. Tani, N. Shudo, and S.-I. Akiyama Reversal of Multidrug Resistance-Associated Protein-Mediated Drug Resistance by the Pyridine Analog PAK-104P Mol. Pharmacol., March 1, 1997; 51(3): 399 - 405. [Abstract] [Full Text] [PDF]

				K. N. Meyer, E. Kjeldsen, T. Straub, B. R. Knudsen, I. D. Hickson, A. Kikuchi, H. Kreipe, and F. Boege Cell Cycle-coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities J. Cell Biol., February 24, 1997; 136(4): 775 - 788. [Abstract] [Full Text] [PDF]

				R. Ishida, M. Iwai, K. L. Marsh, C. A. Austin, T. Yano, M. Shibata, N. Nozaki, and A. Hara Threonine 1342in Human Topoisomerase IIalpha Is Phosphorylated Throughout the Cell Cycle J. Biol. Chem., November 22, 1996; 271(47): 30077 - 30082. [Abstract] [Full Text] [PDF]

				K. Kimura, N. Nozaki, T. Enomoto, M. Tanaka, and A. Kikuchi Analysis of M Phase-specific Phosphorylation of DNA Topoisomerase II J. Biol. Chem., August 30, 1996; 271(35): 21439 - 21445. [Abstract] [Full Text] [PDF]

				K. Kimura, M. Saijo, M. Tanaka, and T. Enomoto Phosphorylation-independent Stimulation of DNA Topoisomerase IIalpha Activity J. Biol. Chem., May 3, 1996; 271(18): 10990 - 10995. [Abstract] [Full Text] [PDF]

				C. W. Sachs, A. R. Safa, S. D. Harrison, and R. L. Fine Partial Inhibition of Multidrug Resistance by Safingol Is Independent of Modulation of P-glycoprotein Substrate Activities and Correlated with Inhibition of Protein Kinase C J. Biol. Chem., November 3, 1995; 270(44): 26639 - 26648. [Abstract] [Full Text] [PDF]

				A. Yokomizo, K. Kohno, M. Wada, M. Ono, C. S. Morrow, K. H. Cowan, and M. Kuwano Markedly Decreased Expression of Glutathione S-Transferase [IMAGE] Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis J. Biol. Chem., August 18, 1995; 270(33): 19451 - 19457. [Abstract] [Full Text] [PDF]